Clinical Study of Abuse-Deterrent Formulation to Suppress Release of Hydrocodone

A number of the abuse-deterrent formulations in development and available on the market utilize hard-to-crush tablet technologies. Frontage possesses wide experience in running studies with controlled substances. Frontage provided full support in developing the protocol, revising study methodology, developing full package for IRB submission, including Informed Consent Form.

"*" indicates required fields

X/Twitter